Stem cells: Promise to cure?
- Isogenic iPSC-derived models of disease. Niemitz, Emily // Nature Genetics;Jan2014, Vol. 46 Issue 1, p7
The article informs that researchers including Stuart Lipton and Rudolf Jaenisch found that a MEF2CPGC1Î±â€“ mediated neuroprotective pathway can be used as a genetic target to develop therapeutic for Parkinson's disease and used using induced pluripotent stem cells (iPSCs) for the research.
- Corrigendum: Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Lister, Ryan; Pelizzola, Mattia; Kida, Yasuyuki S.; Hawkins, R. David; Nery, Joseph R.; Hon, Gary; Antosiewicz-Bourget, Jessica; O'Malley, Ronan; Castanon, Rosa; Klugman, Sarit; Downes, Michael; Yu, Ruth; Stewart, Ron; Ren, Bing; Thomson, James A.; Evans, Ronald M.; Ecker, Joseph R. // Nature;10/2/2014, Vol. 514 Issue 7520, p126
A correction to the article "Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cell" that was published in the March 03, 2011 issue is presented
- Progress on stem cell research towards the treatment of Parkinson's disease. Gibson, Stuart A. J.; Guo-Dong Gao; McDonagh, Katya; Sanbing Shen // Stem Cell Research & Therapy;2012, Vol. 3 Issue 2, p1
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive accumulation of Lewy body inclusions along with selective destruction of dopaminergic (DA) neurons in the nigrostriatal tract of the brain. Genetic studies have revealed much about the pathophysiology of...
- Advances in Induced Pluripotent Stem Cell Technologies. Pal, Rajarshi; Rao, Mahendra; Vemuri, Mohan C.; Verma, Paul; Dinnyes, Andras // Stem Cells International;2012, p1
An introduction is presented in which the editor discusses various reports within the issue on topics including the technological advancements in the field of induced pluripotent stem cells (iPSC).
- Down's Neurons from iPSCs Offer Clues. Breindl, Anette // BioWorld Today;6/3/2013, Vol. 24 Issue 105, Special section p1
The article discusses research on induced pluripotent stem cells (iPSCs) with a triplicate set of chromosome 21 in individuals with Down syndrome, published in the May 27, 2013 online issue of the "Proceedings of the National Academy of Sciences."
- Briefings. // American Scientist;Nov/Dec2014, Vol. 102 Issue 6, p409
The article presents abstracts on science topics in various periodicals including "Systematic Identification of Barriers to Human iPSC Generation" by H. Qin in the July 17, 2014 issue of "Cell," "The Laniakea Supercluster of Galaxies" by R. B. Tully, H. Courtois, Y. Hoffman, and D. Pomarede in...
- What is the point of large-scale collections of human induced pluripotent stem cells? McKernan, Ruth; Watt, Fiona M // Nature Biotechnology;Oct2013, Vol. 31 Issue 10, p875
A letter to the editor is presented related to the study "What is the point of large-scale collections of human induced pluripotent stem cells" by Ruth McKernan and Fiona M Watt in October 2013 issue.
- Program and Abstracts of the 12th Transgenic Technology Meeting (TT2014). // Transgenic Research;Oct2014, Vol. 23 Issue 5, p827
The article presents abstracts on transgenic technology which include the research in induced pluripotent stem (iPS) cell technology and gene editing, in-vivo validation of cancer genes and drug targets, and embryonic stem cells.
- 60 SECONDS. // New Scientist;7/27/2013, Vol. 219 Issue 2927, p7
The article presents science news briefs on topics including the response of the World Health Organization to the Middle East coronavirus outbreak, confiscation of elephant tusks by Hong Kong customs agents on a ship from Togo, and clinical trials of induced pluripotent stem cells.